TAYO HAIYEDE: Open Payments
NPI 1962586354 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 26 payments from 13 companies in 2025. Trend: 2023 $16 · 2024 $247 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $151 |
| TG Therapeutics, Inc. | 3 | $81 |
| ABBVIE INC. | 3 | $53 |
| Lilly USA, LLC | 2 | $33 |
| Alexion Pharmaceuticals, Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Genentech USA, Inc. | 1 | $18 |
Products named: CAPLYTA, BRIUMVI, VRAYLAR, ULTOMIRIS, Wegovy, AUSTEDO XR, DUPIXENT, CREXONT.
Industry payments across SC — which companies pay providers there.
